Extracorporeal Life Support
9
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
CytOSorb TreatMent Of Critically Ill PatientS Registry
A Follow-up Study of Neonates Receiving Extracorporeal Life Support in China
Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support
Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS)
Optic Nerve Sheath Diameter and the Duration of Extracorporeal Life Support During Newborn Cardiac Surgery
Post-Surgery Extracorporeal Life Support
Hypotension During Extracorporeal Circulatory Support Indicated for Cardiogenic Shock
Cardiac Arrest Extra Corporeal Oxygenation Membrane
Extubation of Patients on ECLS is Associated With a Reduction in Complications Related to Mechanical Ventilation: Retrospective Single-centre Study